Skip to main content
. 2016 Jul 20;2016:3251046. doi: 10.1155/2016/3251046

Table 3.

Cell cycle phase distribution (%) of 72-hour THL-treated BT-474 cells showing increasing SubG1 fraction and S-phase arrest.

Treatment SubG1 (%) Cell cycle distribution
G1 (%) S (%) G2/M (%)
PBS 0.8 72.2 12.8 15.0
THL 0.75 mg/mL 3.8 67.5 16.7 15.8
THL 1.5 mg/mL 13.5 65.8 17.7 16.6
THL 3 mg/mL 27.3 55.8 27.7 16.5
THL 6 mg/mL 50.1 50.7 36.9 12.4